SABRIL (Lundbeck Pharmaceuticals LLC)


Welcome to the PulseAid listing for the SABRIL drug offered from Lundbeck Pharmaceuticals LLC. This Anti-epileptic Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Lundbeck Pharmaceuticals LLC
NON-PROPRIETARY NAME: vigabatrin
SUBSTANCE NAME: VIGABATRIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-08-21
END MARKETING DATE: 0000-00-00


SABRIL HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSABRIL from Lundbeck Pharmaceuticals LLC
LABELER NAME: Lundbeck Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2009-08-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67386-111_d0c766cd-a1c9-4a91-9d94-09e3a36c7466
PRODUCT NDC: 67386-111
APPLICATION NUMBER: NDA020427

Other VIGABATRIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Lundbeck Pharmaceuticals LLCSABRIL
Par Pharmaceutical, Inc.VIGABATRIN